Chronic antidepressant treatment accelerates kindling epileptogenesis in rats

Chronic antidepressant treatment accelerates kindling epileptogenesis in rats

Objectives: Due to the high comorbidity of epilepsy and depression, antidepressant treatment is commonly indicated for patients with epilepsy. Studies in humans and animal models suggest that selective serotonin reuptake inhibitors (SSRIs) may reduce seizure frequency and severity, and these drugs a...

Full description

Bibliographic Details
Main Authors:	Lisa Cardamone, Michael R. Salzberg, Amelia S. Koe, Ezgi Ozturk, Terence J. O'Brien, Nigel C. Jones
Format:	Article
Language:	English
Published:	Elsevier 2014-03-01
Series:	Neurobiology of Disease
Subjects:	Selective serotonin reuptake inhibitor Epilepsy Antidepressant Depression Epileptogenesis Animal model
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996113003331

Similar Items

Antidepressants and cardiovascular adverse events: A narrative review
by: Mohammad Hassan Nezafati, et al.
Published: (2015-09-01)

Antidepressants with antimicrobial activity? A promising therapeutic strategy
by: Gloria M. González, et al.
Published: (2022-07-01)

Study of antinociceptive activity of SSRI (fluoxetine and escitalopram) and atypical antidepressants (venlafaxine and mirtazepine) and their interaction with morphine and naloxone in mice
by: Pranav Sikka, et al.
Published: (2011-01-01)

Seizure reduction with fluoxetine in an adult woman with Dravet syndrome
by: Kimford J. Meador
Published: (2014-01-01)

Too Much and Too Little: Antidepressant Treatment in Stroke Survivors during the First Year
by: Katja Werheid, et al.
Published: (2022-06-01)

Antidepressants as a potential candidate to reduce microglia activation in neurodegenerative diseases. A systematic review and meta-analysis of preclinical studies
by: Lisa Nicolai, et al.
Published: (2023-01-01)

Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: Relationship with hippocampal serotonin and norepinephrine transporter expression and function.
by: Nathan C Mitchell, et al.
Published: (2013-10-01)

Editorial: Glial Dysfunction in Epileptogenesis
by: Kjell Heuser, et al.
Published: (2021-07-01)

Antidepressant use and risk of intubation or death in hospitalized patients with COVID-19: A retrospective cohort study of clinical effectiveness
by: Brian P. Brennan, et al.
Published: (2022-09-01)

Immune Mechanism of Epileptogenesis and Related Therapeutic Strategies
by: María José Aguilar-Castillo, et al.
Published: (2022-03-01)

Design and Synthesis of Arylamidine Derivatives as Serotonin/Norepinephrine Dual Reuptake Inhibitors
by: Hui Wen, et al.
Published: (2019-01-01)

Analytical methods for determination of selective serotonin reuptake inhibitor antidepressants
by: Şentürk Zühre, et al.
Published: (2011-06-01)

Role of Hormones and Neurosteroids in Epileptogenesis
by: D Samba eReddy
Published: (2013-07-01)

Update on the Neuroimaging and Electroencephalographic Biomarkers of Epileptogenesis: A Literature Review
by: Guihua Chen, et al.
Published: (2021-08-01)

Age Dependency of Trauma-Induced Neocortical Epileptogenesis
by: Igor eTimofeev, et al.
Published: (2013-09-01)

The role of dendritic spines in epileptogenesis
by: Gary Jean, et al.
Published: (2023-08-01)

Main mechanisms and features of epileptogenesis of post-traumatic epilepsy
by: S. A. Antonenko
Published: (2019-10-01)

Main mechanisms and features of epileptogenesis of post-traumatic epilepsy
by: S. A. Antonenko
Published: (2019-10-01)

Epileptogenesis, traumatic brain injury, and biomarkers
by: Jerome Engel, Jr
Published: (2019-03-01)

Trends in Antidepressant Use and Expenditure in Six Major Cities in China From 2013 to 2018
by: Zhenwei Yu, et al.
Published: (2020-07-01)

The relationship of sleep mechanisms and epileptogenesis
by: A. B. Kozhokaru, et al.
Published: (2020-03-01)

Shortcomings of Trials Assessing Antidepressants in the Management of Irritable Bowel Syndrome: A Critical Review
by: Sun Jung Oh, et al.
Published: (2020-09-01)

Selective serotonin reuptake inhibitor (SSRI) antidepressants, prolactin and breast cancer
by: Janet eAshbury, et al.
Published: (2012-12-01)

Kininogen Level in the Cerebrospinal Fluid May Be a Potential Biomarker for Predicting Epileptogenesis
by: Jing Zou, et al.
Published: (2019-01-01)

Serotonin antidepressants and atrial fibrillation burden from cardiac implantable electronic devices
by: Youlin Koh, et al.
Published: (2023-12-01)

Role of DNA Methylation and Adenosine in Ketogenic Diet for Pharmacoresistant Epilepsy: Focus on Epileptogenesis and Associated Comorbidities
by: Fan Chen, et al.
Published: (2019-02-01)

Neuronal mechanisms of epileptogenesis
by: Roberto eDi Maio, et al.
Published: (2014-02-01)

Interaction between sex and early-life stress: Influence on epileptogenesis and epilepsy comorbidities
by: Nigel C. Jones, et al.
Published: (2014-12-01)

Diversity of kindling of limbic seizures after lateral fluid percussion injury in the rat
by: Jesús‐Servando Medel‐Matus, et al.
Published: (2021-06-01)

Prenatal antidepressant exposure and emotional disorders until age 22: a danish register study
by: Mette Bliddal, et al.
Published: (2023-06-01)

The potential role of DNA methylation as preventive treatment target of epileptogenesis
by: Toni Christoph Berger, et al.
Published: (2022-07-01)

Spatial and temporal profile of high-frequency oscillations in posttraumatic epileptogenesis
by: Lin Li, et al.
Published: (2021-12-01)

Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis
by: Juntao Yin, et al.
Published: (2023-11-01)

Partial TrkB receptor activation suppresses cortical epileptogenesis through actions on parvalbumin interneurons
by: Feng Gu, et al.
Published: (2018-05-01)

The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
by: McIntyre RS
Published: (2017-11-01)

Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial
by: Michael Frey, et al.
Published: (2023-08-01)

PREMATURE EJACULATION: CURRENT ASPECTS ON DIAGNOSIS AND TREATMENT. INTERDISCIPLINARY UROLOGICAL CONCILIUM
by: O. B. Zhukov, et al.
Published: (2018-08-01)

Which adverse effects influence the dropout rate in selective serotonin reuptake inhibitor (SSRI) treatment? Results for 50,824 patients
by: Kostev, Karel, et al.
Published: (2014-10-01)

A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial
by: George Salaminios, et al.
Published: (2017-10-01)

Comparative efficacy and acceptability of selective serotonin reuptake inhibitor antidepressants for binge eating disorder: A network meta-analysis
by: Hanying Duan, et al.
Published: (2022-09-01)